Recently, Nanjing Baifu Laser Technology Co., Ltd. (hereinafter “Nanjing Baifu”) announced the completion of a nearly hundred million yuan Series A financing round, led by YuanSheng Venture Capital and followed by Northern Light Venture Capital. Nanjing Baifu stated that the proceeds will be used for the clinical registration in China and global market promotion of domestically produced mid to high end aesthetic medical optoelectronic devices, including picosecond lasers, erbium lasers, alexandrite lasers, and dye lasers.
Nanjing Baifu is a technology driven high end aesthetic medical optoelectronic equipment company. At present, the company focuses on the independent R&D, production, sales, and scientific research services of innovative products in the fields of dermatology, plastic surgery, rehabilitation medicine, and general wellness.
Beijing Caihe Law Firm conducted Freedom to Operate (FTO) due diligence for patent infringement risks in this financing round.
